Published in Proc Natl Acad Sci U S A on January 01, 1985
Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol (1988) 7.06
Escherichia coli cell division protein FtsZ is a guanine nucleotide binding protein. Proc Natl Acad Sci U S A (1993) 4.46
Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci U S A (1986) 2.93
Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site. EMBO J (1986) 2.85
Mutational analysis of a ras catalytic domain. Mol Cell Biol (1986) 2.76
Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol Cell Biol (1988) 2.57
Isolation of ras GTP-binding mutants using an in situ colony-binding assay. Proc Natl Acad Sci U S A (1986) 2.35
Direct identification of palmitic acid as the lipid attached to p21ras. Mol Cell Biol (1986) 2.02
Microinjection of transforming ras protein induces c-fos expression. Mol Cell Biol (1987) 1.91
Proteolytic processing of avian sarcoma and leukosis viruses pol-endo recombinant proteins reveals another pol gene domain. J Virol (1987) 1.85
The ras oncogene--an important regulatory element in lower eucaryotic organisms. Microbiol Rev (1989) 1.79
The ras-related mouse ypt1 protein can functionally replace the YPT1 gene product in yeast. EMBO J (1989) 1.79
rasH mutants deficient in GTP binding. Mol Cell Biol (1986) 1.73
Mutations of the ras gene product p21 that abolish guanine nucleotide binding. Proc Natl Acad Sci U S A (1986) 1.71
Biochemical and biological properties of the human N-ras p21 protein. Mol Cell Biol (1987) 1.65
Biochemical properties of the ras-related YPT protein in yeast: a mutational analysis. EMBO J (1987) 1.61
Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene. J Virol (1985) 1.44
Induction of neurite formation in PC12 cells by microinjection of proto-oncogenic Ha-ras protein preincubated with guanosine-5'-O-(3-thiotriphosphate). Mol Cell Biol (1987) 1.41
Activation of ras p21 transforming properties associated with an increase in the release rate of bound guanine nucleotide. Mol Cell Biol (1986) 1.36
Identification and preliminary characterization of protein-cysteine farnesyltransferase. Proc Natl Acad Sci U S A (1990) 1.33
The ras1 function of Schizosaccharomyces pombe mediates pheromone-induced transcription. EMBO J (1992) 1.28
Regulated expression of ras gene constructs in Dictyostelium transformants. Proc Natl Acad Sci U S A (1985) 1.16
Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains. EMBO J (1985) 1.16
Neutralizing monoclonal antibody against ras oncogene product p21 which impairs guanine nucleotide exchange. Mol Cell Biol (1987) 1.16
ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 function. Proc Natl Acad Sci U S A (1986) 1.16
Monoclonal antibody Y13-259 recognizes an epitope of the p21 ras molecule not directly involved in the GTP-binding activity of the protein. Mol Cell Biol (1986) 1.15
Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis. Mol Cell Biol (1987) 1.12
A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene. Mol Cell Biol (1986) 1.11
Characterization of a factor that stimulates hydrolysis of GTP bound to ras gene product p21 (GTPase-activating protein) and correlation of its activity to cell density. Mol Cell Biol (1988) 1.10
Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes. Mol Cell Biol (1986) 1.09
The biochemistry of ras p21. Biochem J (1991) 1.08
Human cancer and cellular oncogenes. Biochem J (1987) 1.07
pTAR-encoded proteins in plasmid partitioning. J Bacteriol (2000) 1.07
Expression of the Kirsten ras viral and human proteins in Escherichia coli. J Virol (1987) 1.02
NMR-based functional profiling of RASopathies and oncogenic RAS mutations. Proc Natl Acad Sci U S A (2013) 1.02
A single point mutation of Ala-25 to Asp in the 14,000-Mr envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus. J Virol (1989) 1.02
Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP-binding and transforming activities. EMBO J (1986) 1.01
RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally. Front Genet (2012) 0.99
Aberrant transmembrane signal transduction in Dictyostelium cells expressing a mutated ras gene. Proc Natl Acad Sci U S A (1987) 0.99
Abundant expression of ras proteins in Aplysia neurons. J Cell Biol (1986) 0.88
What we could do now: molecular pathology of colorectal cancer. Mol Pathol (2001) 0.88
Cellular oncogenes in neoplasia. J Clin Pathol (1987) 0.87
Decreased expression of Ras GTPase activating protein in human trophoblastic tumors. Am J Pathol (1995) 0.85
Identification of resonances from an oncogenic activating locus of human N-RAS-encoded p21 protein using isotope-edited NMR. Proc Natl Acad Sci U S A (1989) 0.84
Monoclonal antibody specific for an activated RAS protein. Proc Natl Acad Sci U S A (1986) 0.82
Antibody of predetermined specificity to a carboxy-terminal region of H-ras gene products inhibits their guanine nucleotide-binding function. Mol Cell Biol (1985) 0.82
Characterization of phosphoinositide-specific phospholipase C from human platelets. Biochem J (1987) 0.82
Transforming ras proteins accelerate hormone-induced maturation and stimulate cyclic AMP phosphodiesterase in Xenopus oocytes. Mol Cell Biol (1990) 0.80
H-ras mutants lacking the epitope for the neutralizing monoclonal antibody Y13-259 show decreased biological activity and are deficient in GTPase-activating protein interaction. Mol Cell Biol (1989) 0.80
Genetic prognostic markers in colorectal cancer. Mol Pathol (1997) 0.79
MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer. Drug Dev Res (2015) 0.78
Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21. Proc Natl Acad Sci U S A (1985) 0.77
Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix. J Clin Pathol (1998) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Mechanism of activation of a human oncogene. Nature (1982) 12.09
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (1982) 11.92
Cellular oncogenes and retroviruses. Annu Rev Biochem (1983) 10.65
Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol (1982) 8.88
The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature (1981) 8.44
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature (1982) 6.78
Comparative biochemical properties of normal and activated human ras p21 protein. Nature (1984) 6.50
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature (1982) 6.09
Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues. Mol Cell Biol (1982) 5.70
Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci U S A (1981) 5.51
Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci U S A (1982) 5.39
ras-Related gene sequences identified and isolated from Saccharomyces cerevisiae. Nature (1984) 5.32
Structure and activation of the human N-ras gene. Cell (1983) 5.25
A yeast gene encoding a protein homologous to the human c-has/bas proto-oncogene product. Nature (1984) 5.19
T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature (1982) 4.54
Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature (1983) 4.44
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature (1982) 4.44
Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus. Nature (1980) 4.43
Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature (1984) 4.38
Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature (1983) 4.34
Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses. Proc Natl Acad Sci U S A (1979) 4.34
Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature (1983) 4.15
Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus. Science (1982) 3.55
Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci U S A (1982) 3.48
Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature (1984) 3.15
Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature (1983) 3.09
Three human transforming genes are related to the viral ras oncogenes. Proc Natl Acad Sci U S A (1983) 3.06
Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genes. J Virol (1982) 2.91
Characterization of transducin from bovine retinal rod outer segments. I. Separation and reconstitution of the subunits. J Biol Chem (1983) 2.72
Comparison of the genomic organization of Kirsten and Harvey sarcoma viruses. J Virol (1978) 2.66
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu. Proc Natl Acad Sci U S A (1974) 1.97
Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins. Proc Natl Acad Sci U S A (1984) 1.94
Spontaneous activation of a human proto-oncogene. Proc Natl Acad Sci U S A (1983) 1.90
Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes. Proc Natl Acad Sci U S A (1984) 1.89
Homologies in the primary structure of GTP-binding proteins: the nucleotide-binding site of EF-Tu and p21. EMBO J (1984) 1.88
Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21. Cell (1984) 1.76
Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.55
Photoaffinity labeling with GTP of viral p21 ras protein expressed in Escherichia coli. J Virol (1984) 1.54
[Determination of orthophosphate in the presence of phosphate compounds with an affinity for acids and molybdate]. Biochem Z (1958) 1.49
High-level expression in Escherichia coli of enzymatically active Harvey murine sarcoma virus p21ras protein. Science (1983) 1.38
Frequent activation of c-kis as a transforming gene in fibrosarcomas induced by methylcholanthrene. Science (1983) 1.38
Rhodopsin-enhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase. J Biol Chem (1984) 1.33
Guanine nucleotide binding activity of the src gene product of rat-derived murine sarcoma viruses. Ann N Y Acad Sci (1980) 1.27
Presence of a Kirsten murine sarcoma virus ras oncogene in cells transformed by 3-methylcholanthrene. Mol Cell Biol (1983) 1.18
Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu. Biochemistry (1981) 0.81
GTPase activity associates with the inhibitory GTP-binding regulatory component of adenylate cyclase purified from rat brain. FEBS Lett (1984) 0.80
Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med (1988) 7.12
Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature (1984) 3.15
Mutational analysis of a ras catalytic domain. Mol Cell Biol (1986) 2.76
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A (1998) 2.54
Universal cellular tropism? Nature (1992) 2.18
Microinjection of transforming ras protein induces c-fos expression. Mol Cell Biol (1987) 1.91
A novel membrane factor stimulates guanine nucleotide exchange reaction of ras proteins. FEBS Lett (1990) 1.76
Sulfur metabolism in Escherichia coli and related bacteria: facts and fiction. J Mol Microbiol Biotechnol (2000) 1.75
Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells. New Biol (1990) 1.71
Regulation of the terminal reactions in methionine biosynthesis by vitamin B 12 and methionine. Arch Biochem Biophys (1972) 1.70
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett (2000) 1.65
Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev (1992) 1.62
Mechanism of translational control by partial phosphorylation of the alpha subunit of eukaryotic initiation factor 2. Proc Natl Acad Sci U S A (1984) 1.57
SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med (1995) 1.56
Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.55
Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain. Biochem Biophys Res Commun (1987) 1.55
Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene (2001) 1.54
DNA-directed in vitro synthesis of proteins involved in bacterial transcription and translation. Proc Natl Acad Sci U S A (1979) 1.50
Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand. J Med Chem (1994) 1.48
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med (2000) 1.48
DNA-directed in vitro synthesis of beta-galactosidase. Studies with purified factors. J Biol Chem (1977) 1.40
Nerve growth factor stimulation of the Ras-guanine nucleotide exchange factor and GAP activities. Science (1992) 1.39
Effect of methionine and vitamin B-12 on the activities of methionine biosynthetic enzymes in metJ mutants of Escherichia coli K12. Arch Biochem Biophys (1973) 1.39
Insulin induction of Xenopus laevis oocyte maturation is inhibited by monoclonal antibody against p21 ras proteins. Mol Cell Biol (1987) 1.39
The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood (1996) 1.37
Inhibition of human immunodeficiency virus infectivity by chloroquine. AIDS Res Hum Retroviruses (1990) 1.34
Identification and preliminary characterization of protein-cysteine farnesyltransferase. Proc Natl Acad Sci U S A (1990) 1.33
Purification of a factor capable of stimulating the guanine nucleotide exchange reaction of ras proteins and its effect on ras-related small molecular mass G proteins. Proc Natl Acad Sci U S A (1990) 1.32
Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis (1996) 1.32
L factor that is required for beta-galactosidase synthesis is the nusA gene product involved in transcription termination. Proc Natl Acad Sci U S A (1980) 1.32
Limiting availability of binding sites for dehydrogenases on the cell membrane of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.31
Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. Proc Natl Acad Sci U S A (1999) 1.30
MAP 30: a new inhibitor of HIV-1 infection and replication. FEBS Lett (1990) 1.30
Purification and characterization of a cytosolic 65-kilodalton phosphoprotein in human leukocytes whose phosphorylation is augmented by stimulation with interleukin 1. Biochemistry (1988) 1.27
Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer (1991) 1.26
In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 1.24
Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse (1997) 1.23
Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene (1995) 1.22
Direct evidence for an intracellular role for tumor necrosis factor-alpha 1. Microinjection of tumor necrosis factor kills target cells. J Immunol (1990) 1.22
Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int J Cancer (2001) 1.20
Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J Med Chem (2001) 1.20
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther (2000) 1.20
Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C. Science (1990) 1.20
Studies on the role of ribosomal proteins L 7 and L 12 in the in vitro synthesis of -galactosidase. J Biol Chem (1973) 1.19
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase. J Med Chem (1999) 1.19
A truncated bone morphogenetic protein 4 receptor alters the fate of ventral mesoderm to dorsal mesoderm: roles of animal pole tissue in the development of ventral mesoderm. Proc Natl Acad Sci U S A (1994) 1.19
Negative regulation of human immune deficiency virus replication in monocytes. Distinctions between restricted and latent expression in THP-1 cells. J Exp Med (1990) 1.18
Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc Natl Acad Sci U S A (1995) 1.18
Deduced amino acid sequence of bovine retinal Go alpha: similarities to other guanine nucleotide-binding proteins. Proc Natl Acad Sci U S A (1987) 1.17
A dominant negative bone morphogenetic protein 4 receptor causes neuralization in Xenopus ectoderm. Biochem Biophys Res Commun (1995) 1.16
Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains. EMBO J (1985) 1.16
Regulation of intracellular actin polymerization by prenylated cellular proteins. J Cell Biol (1992) 1.16
Gamma-glutamylmethylamide. A new intermediate in the metabolism of methylamine. J Biol Chem (1969) 1.14
Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. J Med Chem (1997) 1.14
The gene for the human immune interferon receptor is located on chromosome 6. Proc Natl Acad Sci U S A (1986) 1.14
Phospholipase C-gamma 1 can induce DNA synthesis by a mechanism independent of its lipase activity. Proc Natl Acad Sci U S A (1994) 1.12
Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells. Virology (1996) 1.12
A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene. Mol Cell Biol (1986) 1.11
Mu opioid receptor gene expression in immune cells. Biochem Biophys Res Commun (1995) 1.11
Filtering of ineffective siRNAs and improved siRNA design tool. Bioinformatics (2004) 1.10
TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells. Proc Natl Acad Sci U S A (1991) 1.09
Oxidation of C-1 compounds by Pseudomonas sp. MS. Biochem J (1970) 1.08
Induction of transformation and DNA synthesis after microinjection of raf proteins. Mol Cell Biol (1990) 1.08
Direct evidence for an intracellular role for IFN-gamma. Microinjection of human IFN-gamma induces Ia expression on murine macrophages. J Immunol (1990) 1.08
Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol (1982) 1.08
Loss of cell adhesion in Xenopus laevis embryos mediated by the cytoplasmic domain of XLerk, an erythropoietin-producing hepatocellular ligand. Proc Natl Acad Sci U S A (1998) 1.07
Reversal of transformed phenotype by monoclonal antibodies against Ha-ras p21 proteins. Exp Cell Res (1986) 1.07
Polypeptide chain initiation in eukaryotes: reversibility of the ternary complex-forming reaction. Proc Natl Acad Sci U S A (1983) 1.07
S-phase induction and transformation of quiescent NIH 3T3 cells by microinjection of phospholipase C. Proc Natl Acad Sci U S A (1989) 1.07
IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nucl Med Biol (2001) 1.07
Purified yeast protein farnesyltransferase is structurally and functionally similar to its mammalian counterpart. Biochem J (1993) 1.06
Human immunodeficiency virus type 1 (HIV-1) inhibition, DNA-binding, RNA-binding, and ribosome inactivation activities in the N-terminal segments of the plant anti-HIV protein GAP31. Proc Natl Acad Sci U S A (1994) 1.05
Effects of age on dopamine transporters in healthy humans. J Nucl Med (1999) 1.04
Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med (1996) 1.04
Nicotinic acid metabolism. VI. Purification and properties of alpha-methyleneglutarate mutase (B 12-dependent) and methylitaconate isomerase. J Biol Chem (1971) 1.03
Characterization of human and mouse peroxiredoxin IV: evidence for inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species. Antioxid Redox Signal (2000) 1.03
Characterization of receptors for immune interferon in U937 cells with 32P-labeled human recombinant immune interferon. J Biol Chem (1985) 1.03
Studies on the in vitro synthesis of beta-galactosidase: necessary components in the ribosomal wash. Arch Biochem Biophys (1974) 1.03
Anti-HIV plant proteins catalyze topological changes of DNA into inactive forms. Biofactors (1992) 1.02
Small and neutral Tc(v)O BAT, bisaminoethanethiol (N2S2) complexes for developing new brain imaging agents. Nucl Med Biol (1998) 1.02
Regulation of primary erythropoiesis in the ventral mesoderm of Xenopus gastrula embryo: evidence for the expression of a stimulatory factor(s) in animal pole tissue. Dev Biol (1994) 1.01
Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med (2000) 1.01
12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis (2001) 1.01
A new class of anti-HIV agents: GAP31, DAPs 30 and 32. FEBS Lett (1991) 1.01
Effects of ras-encoded proteins and platelet-derived growth factor on inositol phospholipid turnover in NRK cells. Proc Natl Acad Sci U S A (1988) 1.00
Nicotinic acid metabolism. V. A cobamide coenzyme-dependent conversion of alpha-methyleneglutaric acid to dimethylmaleic acid. Proc Natl Acad Sci U S A (1970) 1.00
4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies. J Pharmacol Exp Ther (1995) 0.99
Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis (2001) 0.99
Inhibitory effect of D-glucosamine and other sugars on the biosynthesis of protein, ribonucleic acid, and deoxyribonucleic acid in normal and neoplastic tissues. J Biol Chem (1969) 0.99
Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulation. Mol Carcinog (2001) 0.98
Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease. J Natl Cancer Inst (1996) 0.98
Trimethylsulfonium-tetrahydrofolate methyltransferase, a novel enzyme in the utilization of 1 carbon units. J Biol Chem (1966) 0.98
Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter. Nucl Med Biol (1995) 0.98
A bacteriophage T4 DNA packaging related DNA-dependent ATPase-endonuclease. J Biol Chem (1982) 0.98